Academics decry FDA crackdown on genome service companies

· by · in Biotechnology industry, iPS Cells, Personalized Therapies, Regenerative Medicine. ·

image

 

http://medicalxpress.com/news/2014-01-academics-decry-fda-crackdown-genome.html#ajTabs

Leave a Reply

Fill in your details below or click an icon to log in:

Gravatar
WordPress.com Logo

You are commenting using your WordPress.com account. ( Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. ( Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. ( Log Out /  Change )

Cancel

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.